| VENTURE MARKET SUMMARY |
Note to Readers: VentureWire newsletters are taking a break for the holidays. The last issue of the year will be Friday. Publication will resume January 3, 2002.
| |
 Next Generation Internet Funding Available from CommerceNet |
The complete text of the stories below, as well as 20 additional venture-capital and private-company stories, are available today exclusively to subscribers to our new, premium service, VentureWire Professional. Find out more.
San Francisco Airport Marriott, CA
March 4&5, 2002
Judy
Estrin, President and CEO,
Packet Design
Few entrepreneurs can match Judy's record of companies started and achievements recorded. With husband Bill Carrico, she launched Bridge Communications, an early vendor of network routers later merged with 3Com; Network Computing Devices, a maker of terminals and PC-Unix integration software that went public in 1992; and Precept Software, a developer of software for streaming video that was acquired by Cisco in 1998. During her two-year tenure as chief technology officer of Cisco, Judy was named twice to Fortune magazine's list of the 50 most powerful women in American business. Packet Design, the latest Estrin-Carrico venture, develops technology that addresses security, scalability, and other long-term network design issues with the intent of commercializing them through spin-offs of independent companies or the sale of tools and technologies. And on March 4, as the lunchtime keynote at Network Outlook in Burlingame, you can hear her vision for networking and the internet. Register today to guarantee your place.
----------------------------
The NEW HUMAN CAPITAL ASSET Conference
A Technological Look Forward to the Future Worlds of Work
January 25, 2002
Bell Harbor Int'l Conference Center
Seattle, WA
Kick off 2002 with this compelling one-day educational and planning forum hosted in Seattle on January 25th!
Speakers include analysts and thought leaders from IDC, Watson Wyatt Worldwide, HotJobs.com Ltd, PeopleSoft, Accenture, Sequoia Capital. Keynote by Richard Adler, Principal, People & Technology from Silicon Valley.
http://www.devonjames.com
E-Mail: LookForward@devonjames.com
425.378.1682
your account
• Change your e-mail address
• Thoughts, suggestions, commentary
• Cancel your account
• This newsletter was mailed to you at: rick@TOGETHERWEB.COM
contact
• Send news items to: editor@venturewire.com
• Send questions, complaints, or service queries to: help@venturewire.com
y• Send advertising inquiries to: advertise@venturewire.com
| Winning follow-on capital
- the expert view... There is money out there. Even in these times, private companies with one or two rounds of financing are able to raise another. It's difficult, sure. And takes far too much time and attention away from running your business. Which is why VentureWire is focusing on the process in the latest of its company-building conferences. In a single day out of the office, you'll learn what it takes to get the capital you need in a downturn, which funding sources are right for your startup, and how best to approach them. You'll hear from speakers who are actually doing follow-on rounds outside their own portfolios. And you'll get a discount on the latest VentureWire Research report, which identifies more than a hundred such investors and provides details on more than 600 expansion financings in the last six months in which new investors were involved. Review the agenda agenda and make your registration today. Raising Follow-on Capital in a Buyer's Market a venturewire executive summit February 6, 2002 The Westin, Santa Clara http://events.venturewire.com/followon/Summit |
| Drug Discovery Firm GenoSpectra Raises $20M Series B |  |
| FREMONT, CALIF. -- GenoSpectra, a developer of DNA and
protein micro arrays and high throughput drug screening
applications, said it has raised $20 million in Series B financing.
[more..] http://www.genospectra.com | |
| Ignition's Second Fund Takes Off with $285 Million | |
| BELLEVUE, WASH. -- Ignition Partners, an early stage venture
capital firm, is expected to announce the closing of its second fund
with $285 million. [more..] http://www.ignitioncorp.com | |
| Xantos Biomedicine Secures $19 Million in Second Round | |
| MARTINSRIED, GERMANY -- Xantos Biomedicine, a developer of
functional genomics technology, announced that it has secured EUR 21
million ($19 million) in second-round funding. [more..] http://www.xantos.de | |
| Air Monitoring Firm Aircuity Raises $4.5M in Series A Round | |
| NEWTON, MASS. -- Aircuity, which develops indoor air-quality
monitoring products for commercial buildings, said it raised $4.5
million in its Series A round. [more..] http://www.aircuity.com | |
| Guava Technologies Gets $6M Series D, $5.5 Distribution Deal | |
| BURLINGAME, CALIF. -- Guava Technologies, which develops
cellular analysis systems, announced that it has secured $6 million
in Series D funding. The company also announced that it has entered
into a five-year, $5.5 million agreement with Kobe, Japan-based Bay
Bioscience to manage the distribution of its flagship scale analysis
platform, the Guava Personal Cytometer, to the Japanese market.
[more..] http://www.guavatechnologies.com | |
| Proficient Gets $3M in Series B; Acquires TogetherWeb | |
| ATLANTA -- Proficient Systems, which provides multi-channel
sales optimization software, said it raised near $3 million in its
Series B round and acquired Atlanta-based TogetherWeb, a developer
of collaborative commerce and browsing software, in an all-stock
deal. [more..] http://www.togetherweb.com http://www.proficient.com | |
 With an exclusive licensing agreement with Stanford University and Harvard University's Brigham and Women's hospital, Corgentech has discovered and developed a combination of both drug and device that appears to have overcome the technical problems associated with intracellular molecules. Using the E2F Decoy approach, small double-stranded oligonucleotides are introduced into cells to specifically bind to target transcription factors, thereby, preventing these factors from transactivating their target genes. Corgentech has developed a highly efficient method for the delivery of naked single and double-stranded oligodeoxynucleotides cells and tissues, using controlled, nondistending pressure without use of viral vectors, viral components, lipid formulations or exposure to other adjunctive, potentially hazardous substances. On January 22 at Healthcare Outlook, John Mc Laughlin, President & CEO will be presenting his plans for Corgentech's growth in the Private Equity Platform section of the conference. Register today to guarantee you place at this one day event. Healthcare Outlook January 22, 2002 Redwood City, Calif. http://www.healthcareoutlook.com |
| Medtronic Acquires Endonetics | |
| MINNEAPOLIS -- Medtronic, a publicly traded developer of
medical technology products for chronic disease, announced that it
has acquired San Diego-based Endonetics, a developer of technologies
for the diagnosis and treatment of gastroesophageal reflux disease
(GERD). Financial terms of the transaction were not disclosed.
[more..] http://www.endonetics.com http://www.medtronics.com | |
| PolyTechnos Venture Fund II Has First Close of $108 Million | |
| MUNICH, GERMANY -- PolyTechnos Venture Partners, venture
capital firm that focuses on early-stage technology companies
predominantly in Europe, said it had a first closing of its second
fund, PolyTechnos Venture Fund II, with 120 million EUR ($108
million). [more..] http://www.polytechnos.com | |
| Apax Partners Adds Five to French Team | |
| PARIS -- Apax Partners, a venture capital firm, said it added
five new associates to its French office. [more..] http://www.apax.com | |
tell a friend
VENTUREWIRE INDEX
419.5 -1.22%
 Stephen O'Connor has founded four technology companies in Southern California, including Clinical Micro Sensors, (CMS), which was later bought by Motorola for $300 million. His latest company, Nanostream, is presenting at Healthcare Outlook on January 22, 2002. Founded in 1999, the Pasadena -based biotech tools company helps solve drug discovery and development bottlenecks through mass-customized microfluidics. Join the other investors and executives to hear Stephen O'Connor outline his plans for the continued growth of Nanostream and where the best pharmaceutical market opportunities exist for their Snap-n-Flow system. Register today to guarantee your place. Healthcare Outlook January 22, 2002 Sofitel Redwood Shores, Calif., http://www.healthcareoutlook.com |
To cancel, change, or update your subscription:
http://alert.venturewire.com/account.asp